Can LaTKE cure APBD?

Research TeamUpdates

A collaboration of researchers from Hadassah Medical Center and the Israeli company Pepticom has resulted in the design of a peptide (a very small molecule) that shows promise for APBD patients. The peptide they designed is identified by its components and has the name “LaTKE." Hadassah researchers have already determined that LaTKE works on cells in a laboratory setting. The next step is to extend testing to an APBD mouse model.

A picture is worth a thousand words

- APBDRF winter 2015 newsletter

- Letter from the APBDRF to stakeholders


Goal: $150,000.00

$101,468.01 raised